|
1
|
Brenner H, Rothenbacher D and Arndt V:
Epidemiology of stomach cancer. Methods Mol Biol. 472:467–477.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Desai AM, Pareek M, Nightingale PG and
Fielding JW: Improving outcomes in gastric cancer over 20 years.
Gastric Cancer. 7:196–201. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Crew KD and Neugut AI: Epidemiology of
gastric cancer. World J Gastroenterol. 12:354–362. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Krol J, Loedige I and Filipowicz W: The
widespread regulation of microRNA biogenesis, function and decay.
Nat Rev Genet. 11:597–610. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mukherji S, Ebert MS, Zheng GX, Tsang JS,
Sharp PA and van Oudenaarden A: MicroRNAscan generate thresholds in
target gene expression. Nat Genet. 43:854–859. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Pichinuk E, Broday L and Wreschner DH:
Endogenous RNA cleavages at the ribosomal SRL site likely reflect
miRNA mediated translational suppression. Biochem Biophys Res
Commun. 414:706–711. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang M, Gu H, Qian H, Zhu W, Zhao C, Zhang
X, Tao Y, Zhang L and Xu W: miR-17-5p/20a are important markers for
gastric cancer and murine double minute 2 participates in their
functional regulation. Eur J Cancer. 49:2010–2021. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mitash N, Agnihotri S, Tiwari S, Agrawal V
and Mandhani A: MicroRNA-21 could be a molecular marker to predict
the recurrence of nonmuscle invasive bladder cancer. Indian J Urol.
33:283–290. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jiao W, Leng X, Zhou Q, Wu Y, Sun L, Tan
Y, Ni H, Dong X, Shen T, Liu Y and Li J: Different miR-21-3p
isoforms and their different features in colorectal cancer. Int J
Cancer. 141:2103–2111. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Song Y, Zuo Y, Qian XL, Chen ZP, Wang SK,
Song L and Peng LP: Inhibition of MicroRNA-21-5p promotes the
radiation sensitivity of non-small cell lung cancer through HMSH2.
Cell Physiol Biochem. 43:1258–1272. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Motoyama K, Inoue H, Mimori K, Tanaka F,
Kojima K, Uetake H, Sugihara K and Mori M: Clinicopathological and
prognostic significance of PDCD4 and microRNA-21 in human gastric
cancer. Int J Oncol. 36:1089–1095. 2010.PubMed/NCBI
|
|
13
|
Wu Y, Song Y, Xiong Y, Wang X, Xu K, Han
B, Bai Y, Li L, Zhang Y and Zhou L: MicroRNA-21 (Mir-21) promotes
cell growth and invasion by repressing tumor suppressor PTEN in
colorectal cancer. Cell Physiol Biochem. 43:945–958. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang BG, Li JF, Yu BQ, Zhu ZG, Liu BY and
Yan M: microRNA-21 promotes tumor proliferation and invasion in
gastric cancer by targeting PTEN. Oncol Rep. 27:1019–1026. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang L, Qu J, Zhou L, Liao F and Wang J:
MicroRNA-373 inhibits cell proliferation and invasion via targeting
BRF2 in human non-small cell lung cancer A549 cell line. Cancer Res
Treat. Oct 12–2017.(Epub ahead of print). View Article : Google Scholar :
|
|
16
|
Li Y, Zhang D and Wang J: MicroRNA-373
promotes tumorigenesis of renal cell carcinoma in vitro and in
vivo. Mol Med Rep Sep. 16:7048–7055. 2017. View Article : Google Scholar
|
|
17
|
Hua Y, Chen H, Wang L, Wang F, Wang P,
Ning Z, Li Y, Liu L, Chen Z and Meng Z: Low serum miR-373 predicts
poor prognosis in patients with pancreatic cancer. Cancer Biomark.
20:95–100. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Suh MR, Lee Y, Kim JY, Kim SK, Moon SH,
Lee JY, Cha KY, Chung HM, Yoon HS, Moon SY, et al: Human embryonic
stem cells express a unique set of microRNAs. Dev Biol.
270:488–498. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang X, Yan Z, Zhang J, Gong L, Li W, Cui
J, Liu Y, Gao Z, Li J, Shen L and Lu Y: Combination of hsa-miR-375
and hsa-miR-142-5p as a predictor for recurrence risk in gastric
cancer patients following surgical resection. Ann Oncol.
22:2257–2266. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yan Z, Xiong Y, Xu W, Li M, Cheng Y, Chen
F, Ding S, Xu H and Zheng G: Identification of recurrence-related
genes by integrating microRNA and gene expression profiling of
gastriccancer. Int J Oncol. 41:2166–2174. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang X, Li X, Tan Z, Liu X, Yang C, Ding
X, Hu X, Zhou J, Xiang S, Zhou C and Zhang J: MicroRNA-373 is
upregulated and targets TNFAIP1 in human gastric cancer,
contributing to tumorigenesis. Oncol Lett. 6:1427–1434. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kim KS, Kim JS, Lee MR, Jeong HS and Kim
J: A study of microRNAs in silico and in vivo: Emerging regulators
of embryonic stem cells. FEBS J. 276:2140–2149. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Nakata K, Ohuchida K, Mizumoto K, Aishima
S, Oda Y, Nagai E and Tanaka M: MicroRNA-373 is down-regulated in
pancreatic cancer and inhibits cancer cell invasion. Ann Surg
Oncol. 21 Suppl 4:S564–S574. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Peng Z, Wang CX, Fang EH, Wang GB and Tong
Q: Role of epithelial-mesenchymal transition in gastric cancer
initiation and progression. World J Gastroenterol. 20:5403–5410.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tanaka T, Arai M, Wu S, Kanda T, Miyauchi
H, Imazeki F, Matsubara H and Yokosuka O: Epigenetic silencing of
microRNA-373 plays an important role in regulating cell
proliferation in colon cancer. Oncol Rep. 26:1329–1335.
2011.PubMed/NCBI
|
|
27
|
Cao Y, DePinho RA, Ernst M and Vousden K:
Cancer research: Past, present and future. Nat Rev Cancer.
11:749–754. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Han C, Shen JK, Hornicek FJ, Kan Q and
Duan Z: Regulation of microRNA-1 (miR-1)expression in human cancer.
Biochim Biophys Acta. 1860:227–232. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Matsuda A, Yan IK, Foye C, Parasramka M
and Patel T: MicroRNAs as paracrine signaling mediators in cancers
and metablic diseases. Best Pract Res Clin Endocrinol Metab.
30:577–590. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Huang Q, Gumireddy K, Schrier M, Le Sage
C, Nagel R, Nair S, Egan DA, Li A, Huang G, Klein-Szanto AJ, et al:
The microRNAs miR-373 and miR-520c promote tumour invasion and
metastasis. Nat Cell Bio. 10:202–210. 2008. View Article : Google Scholar
|
|
31
|
Arzumanyan A, Friedman T, Kotei E, Ng IO,
Lian Z and Feitelson MA: Epigeneticrepression of E-cadherin
expression by hepatitis B virus × antigen in liver cancer.
Oncogene. 31:563–572. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Stacy AJ, Craig MP, Sakaram S and Kadakia
M: ΔNp63α and microRNAs: Leveraging the epithelial-mesenchymal
transition. Oncotarget. 8:2114–2129. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Liu P and Wilson MJ: miR-520c and miR-373
upregulate MMP9 expression by targeting mTOR and SIRT1 and activate
the Ras/Raf/MEK/Erk signaling pathway and NF-κB factor in human
fibrosarcoma cells. J Cell Physiol. 227:867–876. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wu W, He X, Kong J and Ye B: Mir-373
affects human lung cancer cells' growth and its E-cadherin
expression. Oncol Res. 20:163–170. 2012. View Article : Google Scholar : PubMed/NCBI
|
